Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience

BACKGROUND: Extrapulmonary small cell carcinomas (ESCC) are rare but aggressive tumors. Relapses are common despite treatment with chemotherapy and/or radiotherapy. Prospective data for treatment of ESCC are lacking; treatment of these cancers usually incorporates lung small cell carcinoma treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Salhab, Mohammed, Migdady, Yazan, Donahue, Melanie, Xiong, Yiqin, Dresser, Karen, Walsh, William, Chen, Benjamin J., Liebmann, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975459/
https://www.ncbi.nlm.nih.gov/pubmed/29843803
http://dx.doi.org/10.1186/s40425-018-0359-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975459/
https://www.ncbi.nlm.nih.gov/pubmed/29843803
http://dx.doi.org/10.1186/s40425-018-0359-1

Ejemplares similares